labetalol has been researched along with saralasin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andréjak, M; Bataille, P; Fournier, A; Gheerbrant, JD; Hardin, JM; Makdassi, R | 1 |
Bar-Andziak, E; Chlewicka, I | 1 |
2 other study(ies) available for labetalol and saralasin
Article | Year |
---|---|
[Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dopamine Antagonists; Humans; Labetalol; Minoxidil; Nifedipine; Prazosin; Renin; Saralasin; Tetrahydronaphthalenes; Vasodilator Agents | 1979 |
[New hypotensive drugs].
Topics: Antihypertensive Agents; Captopril; Drug Evaluation; Guanfacine; Guanidines; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Phenylacetates; Saralasin; Verapamil | 1981 |